Risk factors for CRS and NT with bispecific antibodies: Data from the American bispecifics and CART (ABC) consortium
Reem Karmali, Thomas A. Ollila, Jane N. Winter, Jonathon Brett Cohen et al.
Journal
Blood
Topics
Monoclonal and Polyclonal Antibodies Research
article
Risk factors for CRS and NT with bispecific antibodies: Data from the American bispecifics and CART (ABC) consortium
Reem Karmali, Thomas A. Ollila, Jane N. Winter, Jonathon Brett Cohen, Leo I. Gordon, Geoffrey Shouse, Kyle Miyazaki, Vaishalee Padgaonkar Kenkre, Alexandra Noveihed, Deborah Marie Stephens, Brian T. Hess, Matthew J Cortese, Ari Pelcovits, Jonathan Cruz Moreira, Lindsey A. Fitzgerald, Yun Kyoung Tiger, Tamara Kay Moyo, Megan Melody, Adam Kidwell, Natalie Sophia Grover, Megan M. Herr, Shuo Ma, Daniel Antonio, Narendranath Epperla, James A. Davis, Nirav Niranjan Shah, Colin Thomas, Victoria Gill, Adit Dharia
article en
Abstract
No abstract available for this paper.
Publication Tag
BloodVol. 146(Supplement 1)
Institutions
Rutgers, The State University of New Jersey (US), Northwestern University (US), Roswell Park Comprehensive Cancer Center (US), University of North Carolina Health Care (US), Emory University (US), Medical College of Wisconsin (US), Brown University (US), The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US), Huntsman Cancer Institute (US), Tampa General Hospital (US), MUSC Hollings Cancer Center (US), Levine Cancer Institute (US), Chapel Hill Training Outreach Project (US), University of Wisconsin Carbone Cancer Center (US), City of Hope (US), AdventHealth Tampa (US), Chapel Hill Carrboro City Schools (US), Robert H. Lurie Comprehensive Cancer Center of Northwestern University, University of Pennsylvania (US)